Early phase 2 clinical trial data also suggest a possible contribution to increased energy expenditure, though this effect has not yet been definitively confirmed as a major contributor to weight loss in humans and remains an area of ongoing investigation
The combination of recent surgery, altered anatomy, and GLP-1 therapy demands close monitoring for nausea, vomiting, or other GI symptoms in the first 4 to 6 weeks post-op
Whole grains, nuts, and seeds add both fiber and protein, creating a powerful combination that maximizes GLP-1 stimulation
In our intention-to-treat sensitivity analysis with an additional two years of follow-up, we found an unadjusted HR very similar to the main analysis, although this became a significant protective effect in the fully adjusted analysis
The educational offering comes as Morgan Stanley Research projects that more than 24 million Americans will use weight loss medications by 2035 and consumer spending on GLP-1s has skyrocketed in the United States
Nausea affects roughly 25% of users at higher doses, though rates drop significantly with slow titration